Atlas Trials

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Clinical trial NCT04486378 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04486378
Sponsor
BioNTech SE
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Stage IIColorectal Cancer Stage III
Start date
2021-03-08
Primary completion
2026-11-01
Enrollment
327

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.